125 related articles for article (PubMed ID: 38303255)
1. [The Usefulness of RFA as a Conversion Therapy after Molecular Targeted Therapy for Advanced Hepatocellular Carcinoma-A Case of Long-Term Survival with Multidisciplinary Treatment].
Matsumoto T; Hayashi H; Adachi Y; Kanemitsu K; Tajiri T; Yumoto S; Ogawa D; Shiraishi Y; Takematsu T; Tsukamoto M; Miyata T; Nakagawa S; Mima K; Nitta H; Baba H
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1928-1930. PubMed ID: 38303255
[TBL] [Abstract][Full Text] [Related]
2. Transarterial chemoembolization plus multi-imaging-guided radiofrequency ablation for elimination of hepatocellular carcinoma nodules measuring 3.1 to 5.0 cm: a single-center study.
Haochen W; Jian W; Li S; Tianshi L; Xiaoqiang T; Yinghua Z
J Int Med Res; 2018 Jul; 46(7):2650-2657. PubMed ID: 29683022
[TBL] [Abstract][Full Text] [Related]
3. Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radiofrequency Ablation.
Peng Z; Chen S; Wei M; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Chen M; Qian G; Kuang M
Radiology; 2018 May; 287(2):705-714. PubMed ID: 29390197
[TBL] [Abstract][Full Text] [Related]
4. Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma.
Eggert T; Greten TF
Digestion; 2017; 96(1):1-4. PubMed ID: 28605745
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency ablation combined with chemoembolization for intermediate-sized (3-5 cm) hepatocellular carcinomas under dual guidance of biplane fluoroscopy and ultrasonography.
Min JH; Lee MW; Cha DI; Jeon YH; Shin SW; Cho SK; Rhim H; Lim HK
Korean J Radiol; 2013; 14(2):248-58. PubMed ID: 23483753
[TBL] [Abstract][Full Text] [Related]
6. Combined transarterial chemoembolization and radiofrequency ablation for small treatment-naïve hepatocellular carcinoma infeasible for ultrasound-guided radiofrequency ablation: long-term outcomes.
Hyun D; Cho SK; Shin SW; Park KB; Lee SY; Park HS; Do YS
Acta Radiol; 2018 Jul; 59(7):773-781. PubMed ID: 29034691
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC).
Veltri A; Moretto P; Doriguzzi A; Pagano E; Carrara G; Gandini G
Eur Radiol; 2006 Mar; 16(3):661-9. PubMed ID: 16228211
[TBL] [Abstract][Full Text] [Related]
8. Combination Therapy of Radiofrequency Ablation and Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Retrospective Study.
Tang C; Shen J; Feng W; Bao Y; Dong X; Dai Y; Zheng Y; Zhang J
Medicine (Baltimore); 2016 May; 95(20):e3754. PubMed ID: 27196501
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Small Hepatocellular Carcinoma (≤2 cm) in the Caudate Lobe with Sequential Transcatheter Arterial Chemoembolization and Radiofrequency Ablation.
Hyun D; Cho SK; Shin SW; Rhim H; Koh KC; Paik SW
Cardiovasc Intervent Radiol; 2016 Jul; 39(7):1015-22. PubMed ID: 26975761
[TBL] [Abstract][Full Text] [Related]
10. [Successful Treatment with TACE and RFA for a Hepatocellular Carcinoma Case with Lung Metastasis].
Maeda S; Yasumoto T; Nakamura M; Kitagawa A; Nakahira S; Yasuhara Y; Ushimaru Y; Ohara N; Miyake Y; Kawabata R; Nakata K; Nishikawa K; Noura S; Miyamoto A
Gan To Kagaku Ryoho; 2022 Dec; 49(13):1597-1599. PubMed ID: 36733147
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome of transcatheter arterial chemoembolization after radiofrequency ablation as a combined therapy for Chinese patients with hepatocellular carcinoma.
Xu RC; Liu HC; Li JL; Li K; Ou SY; Yu ZY; Kong Y; Ma GA; Shao WS
Curr Med Res Opin; 2015 Aug; 31(8):1553-60. PubMed ID: 26067770
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma: concomitant sorafenib promotes necrosis after radiofrequency ablation--propensity score matching analysis.
Fukuda H; Numata K; Moriya S; Shimoyama Y; Ishii T; Nozaki A; Kondo M; Morimoto M; Maeda S; Sakamaki K; Morita S; Tanaka K
Radiology; 2014 Aug; 272(2):598-604. PubMed ID: 24689883
[TBL] [Abstract][Full Text] [Related]
13. Medium or Large Hepatocellular Carcinoma: Sorafenib Combined with Transarterial Chemoembolization and Radiofrequency Ablation.
Zhu K; Huang J; Lai L; Huang W; Cai M; Zhou J; Guo Y; Chen J
Radiology; 2018 Jul; 288(1):300-307. PubMed ID: 29688153
[TBL] [Abstract][Full Text] [Related]
14. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study.
Peng Z; Wei M; Chen S; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Kuang M
Eur Radiol; 2018 Aug; 28(8):3522-3531. PubMed ID: 29536241
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation alone versus radiofrequency ablation combined with chemoembolization in unresectable hepatocellular carcinoma.
Siriapisith T; Siwasattayanon P; Tongdee T
J Med Assoc Thai; 2012 Mar; 95(3):430-6. PubMed ID: 22550844
[TBL] [Abstract][Full Text] [Related]
16. Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE).
Iezzi R; Cesario V; Siciliani L; Campanale M; De Gaetano AM; Siciliano M; Agnes S; Giuliante F; Grieco A; Pompili M; Rapaccini GL; Gasbarrini A; Bonomo L;
Radiol Med; 2013 Jun; 118(4):555-69. PubMed ID: 23358819
[TBL] [Abstract][Full Text] [Related]
17. Clinical Outcomes of Radiological Treatment Modalities of Hepatocellular Carcinoma: A Single-Center Experience from Saudi Arabia.
Dahlan YM; Shirah BH; Alghamdi AS; Al Kenawi AA; Sanai FM
Gulf J Oncolog; 2022 May; 1(39):56-62. PubMed ID: 35695347
[TBL] [Abstract][Full Text] [Related]
18. [Quality of life of primary hepatocellular carcinoma patients after radiofrequency ablation].
Wang YB; Chen MH; Yan K; Yang W; Dai Y; Yin SS
Ai Zheng; 2005 Jul; 24(7):827-33. PubMed ID: 16004809
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm].
Yang MJ; An SY; Moon EJ; Lee MS; Hwang JA; Cheong JY; Won JH; Kim JK; Wang HJ; Cho SW
Korean J Hepatol; 2009 Dec; 15(4):474-85. PubMed ID: 20037266
[TBL] [Abstract][Full Text] [Related]
20. Molecular targeting agents associated with transarterial chemoembolization or radiofrequency ablation in hepatocarcinoma treatment.
Ranieri G; Marech I; Lorusso V; Goffredo V; Paradiso A; Ribatti D; Gadaleta CD
World J Gastroenterol; 2014 Jan; 20(2):486-97. PubMed ID: 24574717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
